NIFTY23,8981.14%
SENSEX76,6641.29%
BANKNIFTY56,0900.38%
NIFTY IT28,5315.29%
PHARMA22,5801.77%
AUTO25,6530.68%
FMCG50,7660.73%
METAL12,7470.31%
REALTY778.001.35%
ENERGY39,9040.23%
NIFTY23,8981.14%
SENSEX76,6641.29%
BANKNIFTY56,0900.38%
NIFTY IT28,5315.29%
PHARMA22,5801.77%
AUTO25,6530.68%
FMCG50,7660.73%
METAL12,7470.31%
REALTY778.001.35%
ENERGY39,9040.23%

Motilal Oswal Maintains BUY on LTM with Target Price of INR5,400

LTM, a prominent company, reported revenue of USD1.2 billion in 4QFY26, marking a 1.2% quarter-over-quarter (QoQ) growth in constant currency (CC). This growth fell short of Motilal Oswal's estimate of 1.5% QoQ CC increase.

The company's earnings before interest and taxes (EBIT) margin stood at 15.1%, aligning with Motilal Oswal's estimate of 15.2%. Adjusted profit after tax (PAT) came in at INR13.4 billion, a decline of 4.3% QoQ but an increase of 18.8% year-over-year (YoY). In INR terms, revenue, EBIT, and adj. PAT grew 11.3%, 18.2%, and 16.9% YoY in FY26, respectively.

Growth Rates (INR terms)FY26Motilal Oswal Estimate
Revenue11.3%-
EBIT18.2%-
Adj. PAT16.9%-

Read also: Reliance Industries Nears Green Ammonia Supply Deals with International Partners

Looking ahead to 1QFY27, Motilal Oswal expects revenue, EBIT, and adj. PAT to grow 17.2%, 27.9%, and 20% YoY, respectively. In FY26, free cash flow constituted 78% of net profit, and the return on equity (RoE) came in at 21.3%, down from 23.3% in FY25, 24.4% in FY24, and 26.1% in FY23.

Motilal Oswal maintains its BUY recommendation on LTM with a target price of INR5,400, valuing the company at 23x its estimated earnings per share (EPS) for FY28. This implies a potential upside of approximately 19%. The research firm has cut its estimates for FY27 and FY28 by 2-3% and reaffirms its BUY recommendation.

Investor Takeaway

Motilal Oswal maintains a BUY rating for LTM with a target price of Rs 5400.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
help@iposcanner.ai.

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.